Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Top Cited Papers
- 16 April 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 139 (16), E840-E878
- https://doi.org/10.1161/cir.0000000000000664
Abstract
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic dysfunction in the other organ. It represents the confluence of heart-kidney interactions across several interfaces. These include the hemodynamic cross-talk between the failing heart and the response of the kidneys and vice versa, as well as alterations in neurohormonal markers and inflammatory molecular signatures characteristic of its clinical phenotypes. The mission of this scientific statement is to describe the epidemiology and pathogenesis of cardiorenal syndrome in the context of the continuously evolving nature of its clinicopathological description over the past decade. It also describes diagnostic and therapeutic strategies applicable to cardiorenal syndrome, summarizes cardiac-kidney interactions in special populations such as patients with diabetes mellitus and kidney transplant recipients, and emphasizes the role of palliative care in patients with cardiorenal syndrome. Finally, it outlines the need for a cardiorenal education track that will guide future cardiorenal trials and integrate the clinical and research needs of this important field in the future.Keywords
This publication has 238 references indexed in Scilit:
- Renin-Angiotensin Inhibition in Systolic Heart Failure and Chronic Kidney DiseaseAmerican Journal Of Medicine, 2012
- Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and SurvivalThe American Journal of Cardiology, 2011
- Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levelsHeart Failure Reviews, 2011
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF studyClinical Research in Cardiology, 2010
- Symptom Burden, Depression, and Spiritual Well-Being: A Comparison of Heart Failure and Advanced Cancer PatientsJournal of General Internal Medicine, 2009
- Response to Cardiac Resynchronization Therapy Improves Renal Function: Importance of Forward and Backward FailureJournal of Cardiac Failure, 2009
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart FailureJournal of the American College of Cardiology, 2009
- Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration RateJournal of Cardiac Failure, 2008
- Comparison of Clinical Features and Outcomes of Patients Hospitalized With Heart Failure and Normal Ejection Fraction (≥55%) Versus Those With Mildly Reduced (40% to 55%) and Moderately to Severely Reduced (<40%) FractionsThe American Journal of Cardiology, 2008
- Effects of Angiotensin-Converting Enzyme Inhibitors in Systolic Heart Failure Patients With Chronic Kidney Disease: A Propensity Score AnalysisJournal of Cardiac Failure, 2006